Literature DB >> 8388229

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.

L Damstrup1, K Rygaard, M Spang-Thomsen, H Skovgaard Poulsen.   

Abstract

A panel of 21 small cell lung cancer cell (SCLC) lines were examined for the presence of Transforming growth factor beta receptors (TGF beta-r) and the expression of TGF beta mRNAs. By the radioreceptor assay we found high affinity receptors to be expressed in six cell lines. scatchard analysis of the binding data demonstrated that the cells bound between 4.5 and 27.5 fmol mg-1 protein with a KD ranging from 16 to 40 pM. TGF beta 1 binding to the receptors was confirmed by cross-linking TGF beta 1 to the TGF beta-r. Three classes of TGF beta-r were demonstrated, type I and type II receptors with M(r) = 65,000 and 90,000 and the betaglycan (type III) with M(r) = 280,000. Northern blotting showed expression of TGF beta 1 mRNA in ten, TGF beta 2 mRNA in two and TGF beta 3 mRNA in seven cell lines. Our results provide, for the first time, evidence that a large proportion of a broad panel of SCLC cell lines express TGF beta-receptors and also produce TGF beta mRNAs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388229      PMCID: PMC1968423          DOI: 10.1038/bjc.1993.186

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  49 in total

1.  A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.

Authors:  S Cheifetz; N Ling; R Guillemin; J Massagué
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

2.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.

Authors:  F T Boyd; J Massagué
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

3.  Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.

Authors:  H H Berendsen; L de Leij; E G de Vries; G Mesander; N H Mulder; B de Jong; C H Buys; P E Postmus; S Poppema; H J Sluiter
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

4.  Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes.

Authors:  S B Jakowlew; P J Dillard; M B Sporn; A B Roberts
Journal:  Mol Endocrinol       Date:  1988-12

5.  Identification of another member of the transforming growth factor type beta gene family.

Authors:  P ten Dijke; P Hansen; K K Iwata; C Pieler; J G Foulkes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

7.  The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors.

Authors:  J Bergh
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

8.  Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines.

Authors:  G Söderdahl; C Betsholtz; A Johansson; K Nilsson; J Bergh
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

9.  Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos.

Authors:  D A Miller; A Lee; R W Pelton; E Y Chen; H L Moses; R Derynck
Journal:  Mol Endocrinol       Date:  1989-07

10.  Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.

Authors:  J L Andres; K Stanley; S Cheifetz; J Massagué
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  11 in total

Review 1.  Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Authors:  Slawomir Wojtowicz-Praga
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

2.  Crosstalk of AP4 and TGFβ receptor signaling in NSCLC.

Authors:  Wei Wang; Xinyu Wu; Yu Tian
Journal:  Tumour Biol       Date:  2014-10-01

Review 3.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 4.  Tgf-beta signaling pathway in lung adenocarcinoma invasion.

Authors:  Rebecca L Toonkel; Alain C Borczuk; Charles A Powell
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

Review 5.  Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention.

Authors:  Martin R Jadus; Josephine Natividad; Anthony Mai; Yi Ouyang; Nils Lambrecht; Sandor Szabo; Lisheng Ge; Neil Hoa; Maria G Dacosta-Iyer
Journal:  Clin Dev Immunol       Date:  2012-07-29

6.  Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.

Authors:  P Nørgaard; M Spang-Thomsen; H S Poulsen
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

7.  Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.

Authors:  S Hougaard; P Nørgaard; N Abrahamsen; H L Moses; M Spang-Thomsen; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.

Authors:  T Tsujiuchi; Y Sasaki; M Tsutsumi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2000-10

9.  Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor.

Authors:  P Nørgaard; L Damstrup; K Rygaard; M Spang-Thomsen; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

Review 10.  Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target.

Authors:  Frank Aboubakar Nana; Marie Vanderputten; Sebahat Ocak
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.